Eran Perry
Directeur/Membre du Conseil chez COMPUGEN LTD.
Profil
Mr. Eran Perry is a Co-Founder and Board Member at Upstream Bio, Inc., a Co-Managing Director at Maruho Israel Innovation Fund and a Co-Founder at ICD Pharma Ltd.
He is on the Board of Directors at Upstream Bio, Inc. and Compugen Ltd.
Mr. Perry was previously employed as a Board Member by Musli Thyropeutics Ltd., a Partner by I.H.C.V Israel Healthcare Ventures Ltd., an Associate by Mckinsey & Co. /Israel/, and a Business Analyst by Novartis AG /U.S.
Biologics Manufacturing Operation/.
He received his MBA from Columbia Business School.
Postes actifs de Eran Perry
Sociétés | Poste | Début |
---|---|---|
COMPUGEN LTD. | Directeur/Membre du Conseil | 01/07/2017 |
Maruho Israel Innovation Fund
Maruho Israel Innovation Fund Financial ConglomeratesFinance Maruho Israel Innovation Fund engages in investments in dermatology-related technologies, biotech, medical devices, digital health, and cosmetics. The company was founded by Junichi Hamada, Eran Perry, Doron Friedman, and Masanobu Ogawa in 2018 and is headquartered in Rehovot, Israel. | Directeur Général | 01/01/2018 |
ICD Pharma Ltd. | Fondateur | 01/04/2017 |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Fondateur | 01/04/2021 |
Novartis Oncology | Sales & Marketing | - |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Directeur/Membre du Conseil | - |
Noon Aesthetics Ltd.
Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Noon Aesthetics Ltd. is an Israeli skincare company that focuses on science-based, clinically-proven solutions to enhance the beauty and health of skin. Noon Aesthetics is based in Tel Aviv, IL and was founded in 2012 by Eran Rosman and Masha Minkin. The private company is committed to research and innovation to ensure that their products deliver tangible results and improve the overall well-being of patients. The company's products include the Restart Serum, which helps to repair DNA damage caused by oxidative stress, UV rays, air pollution, pesticides, and aging. Eran Rosman has been the CEO since 2012. | Directeur/Membre du Conseil | - |
Anciens postes connus de Eran Perry
Sociétés | Poste | Fin |
---|---|---|
Musli Thyropeutics Ltd. | Directeur/Membre du Conseil | 01/08/2021 |
I.H.C.V Israel Healthcare Ventures Ltd.
I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures Ltd. (Israel Healthcare Ventures) is a venture capital firm founded in 2000 by Hadar Ron. The firm is headquartered in Tel Aviv, Israel. | Private Equity Investor | 01/09/2016 |
░░░░░░░░ ░░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Eran Perry
Columbia Business School | Masters Business Admin |
Tel-Aviv University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
COMPUGEN LTD. | Health Technology |
Entreprise privées | 10 |
---|---|
I.H.C.V Israel Healthcare Ventures Ltd.
I.H.C.V Israel Healthcare Ventures Ltd. Investment ManagersFinance Israel Healthcare Ventures Ltd. (Israel Healthcare Ventures) is a venture capital firm founded in 2000 by Hadar Ron. The firm is headquartered in Tel Aviv, Israel. | Finance |
Maruho Israel Innovation Fund
Maruho Israel Innovation Fund Financial ConglomeratesFinance Maruho Israel Innovation Fund engages in investments in dermatology-related technologies, biotech, medical devices, digital health, and cosmetics. The company was founded by Junichi Hamada, Eran Perry, Doron Friedman, and Masanobu Ogawa in 2018 and is headquartered in Rehovot, Israel. | Finance |
Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
Mckinsey & Co. /Israel/ | |
Musli Thyropeutics Ltd. | |
ICD Pharma Ltd. | |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Commercial Services |
Novartis Oncology | |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Health Technology |
Noon Aesthetics Ltd.
Noon Aesthetics Ltd. Household/Personal CareConsumer Non-Durables Noon Aesthetics Ltd. is an Israeli skincare company that focuses on science-based, clinically-proven solutions to enhance the beauty and health of skin. Noon Aesthetics is based in Tel Aviv, IL and was founded in 2012 by Eran Rosman and Masha Minkin. The private company is committed to research and innovation to ensure that their products deliver tangible results and improve the overall well-being of patients. The company's products include the Restart Serum, which helps to repair DNA damage caused by oxidative stress, UV rays, air pollution, pesticides, and aging. Eran Rosman has been the CEO since 2012. | Consumer Non-Durables |